Israeli shares continue drop in Wed. morning trade

By SETH FREEDMAN
June 28, 2006 11:21

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israeli shares were still dropping in Wednesday morning trade, with the benchmark TA-25 falling 1.1% to 787.5 - extending the previous session's losses. Africa Israel was the largest percentage decliner, down 2.82%, while Teva Pharmaceutical Industries was also lower after the drug company said it would halt sales of generic Biaxin pending a court ruling. Investment house Clal Finance Batucha cautioned clients about a drop in the market, citing lower global indices as well as security concerns surrounding the army's overnight incursion into Gaza. The TA-25 is now at its lowest level since February 26, and has fallen nearly 13% from its all-time high on May 17.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS